BillionToOne
Medicare Covering BillionToOne Northstar Select Cancer Liquid Biopsy Test
The company's tumor genotyping test will now be reimbursed for eligible Medicare patients under Palmetto GBA's local coverage determination for this class of assays.
With New Validation Data, BillionToOne Boosts Commercial Prospects of Therapy Selection Assay
Premium
The Northstar Select comprehensive genomic profiling test uses BillionToOne's proprietary Quantitative Counting Template technology for solid tumors.